In Vitro Assessment of Urinary Isolates of Ampicillin-Resistant Enterococci

OBJECTIVE: Susceptibility and minimum inhibitory concentration (MIC) studies of ampicillin-resistant enterococci (ARE) were performed with vancomycin, ciprofloxacin, and trovafloxacin. Ampicillin MICs were determined to make comparisons with achievable urinary concentrations of ampicillin. DESIGN: From July 1998 to April 1999, all enterococci isolated from urinary specimens were tested for susceptibility to ampicillin by disk diffusion. For all ARE, vancomycin, ciprofloxacin, and trovafloxacin susceptibilities were determined by use of either disk diffusion or the E-test. Ampicillin MICs were determined for these isolates by liquid agar microdilution testing. ARE were identified to the species level on the basis of biochemical reactions. SETTING: The study was performed at a university-affiliated tertiary care hospital. OUTCOME MEASURES: In vitro susceptibility studies and MIC determinations were performed in accordance with the National Committee for Clinical Laboratory Standards. RESULTS: A total of 310 urine samples were culture positive for enterococcus. Thirty (9.7%) unduplicated isolates were resistant to ampicillin. Of these, nine ARE isolates (30%) were also vancomycin resistant, whereas only 2 ampicillin-susceptible isolates were vancomycin resistant (p < 0.05). All ARE were resistant to ciprofloxacin, and 29 (96.7%) were resistant to trovafloxacin. Nine (30%), 18 (60%), and 3 (10%) isolates had an ampicillin MIC of 128, 256, and 512 μg/mL, respectively. Ampicillin MICs did not differ significantly between vancomycin-susceptible and -resistant isolates (p = 0.963). Twenty-seven isolates (90%) were identified as Enterococcus faecium; the other 3 were either Enterococcus avium or Enterococcus raffinosus. CONCLUSIONS: Ampicillin resistance is associated with resistance to vancomycin. Most ARE are resistant to fluoroquinolone antibiotics such as ciprofloxacin and trovafloxacin. Ampicillin MICs for ARE found in these urinary specimens were all within 1 dilution of 256 μg/mL, a concentration achievable in the urine with higher doses of oral amoxicillin or intravenous ampicillin. Additional studies are needed to assess the clinical implications of these data.

[1]  National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998, issued June 1998. , 1998, American journal of infection control.

[2]  A. ...,et al.  The use of antibiotics : a clinical review of antibacterial, antifungal, and antiviral drugs , 1997 .

[3]  G. Victor,et al.  Risk factors for acquiring ampicillin-resistant enterococci and clinical outcomes at a Canadian tertiary-care hospital , 1994, Journal of clinical microbiology.

[4]  G. Satta,et al.  Overproduction of a low-affinity penicillin-binding protein and high-level ampicillin resistance in Enterococcus faecium , 1994, Antimicrobial Agents and Chemotherapy.

[5]  D. Sexton,et al.  A Case-Control Study of Nosocomial Ampicillin-Resistant Enterococcal Infection and Colonization at a University Hospital , 1993, Infection Control &#x0026; Hospital Epidemiology.

[6]  G. Eliopoulos,et al.  Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution , 1991, Antimicrobial Agents and Chemotherapy.

[7]  V. Yu,et al.  Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study , 1991, Antimicrobial Agents and Chemotherapy.

[8]  C. Watanakunakorn.  Enterococci from blood cultures during 1980-1989: susceptibility to ampicillin, penicillin and vancomycin. , 1990, The Journal of antimicrobial chemotherapy.

[9]  A. A. Goldberg,et al.  Ampicillin-resistant enterococcal species in an acute-care hospital , 1990, Antimicrobial Agents and Chemotherapy.

[10]  B. Murray.  The life and times of the Enterococcus , 1990, Clinical Microbiology Reviews.

[11]  W. J. Tuddenham,et al.  Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem? , 1989, Journal of clinical microbiology.

[12]  M. Wendeler,et al.  High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections. , 1989, Annals of internal medicine.

[13]  M. Zervos,et al.  Enterococcal superinfection in patients treated with ciprofloxacin. , 1988, The Journal of antimicrobial chemotherapy.

[14]  L. Gutmann,et al.  One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to benzylpenicillin. , 1985, Journal of general microbiology.

[15]  R. Moellering.  Enterococcal infections in patients treated with moxalactam. , 1982, Reviews of infectious diseases.

[16]  V. Yu.  Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic. , 1981, Annals of internal medicine.

[17]  M. Cole,et al.  Absence of bioactive metabolites of ampicillin and amoxycillin in man. , 1978, Journal of Antimicrobial Chemotherapy.

[18]  T. Stamey,et al.  Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections. , 1974, The New England journal of medicine.

[19]  A. Bauer,et al.  Antibiotic susceptibility testing by a standardized single disk method. , 1966, American journal of clinical pathology.

[20]  G. Jackson,et al.  TREATMENT OF PYELONEPHRITIS: BACTERIAL, DRUG AND HOST FACTORS IN SUCCESS OR FAILURE AMONG 252 PATIENTS. , 1965, The New England journal of medicine.

[21]  M. Finland,et al.  SODIUM AMPICILLIN: ABSORPTION AND EXCRETION OF INTRAMUSCULART AND INTRAVENOUS DOSES IN NORMAL YOUNG MEN , 1965, The American journal of the medical sciences.